Search Results - "major depression"

Describing the longitudinal course of major depression using Markov models: Data integration across three national surveys by Lee Robert C, Patten Scott B

Connect to this object online.

Social and Economic Factors Associated With Subthreshold and Major Depressive Episode in University Students During the COVID-19 Pandemic by Álvaro I. Langer, Álvaro I. Langer, Álvaro I. Langer, Marcelo A. Crockett, Marcelo A. Crockett, Marcelo A. Crockett, Mariori Bravo-Contreras, Carolina Carrillo-Naipayan, Matías Chaura-Marió, Bárbara Gómez-Curumilla, Claudia Henríquez-Pacheco, Rodrigo C. Vergara, Rodrigo C. Vergara, Jorge Santander, Zayra Antúnez, Zayra Antúnez, Tomas Baader

Connect to this object online.

Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study by Gholamali Jelodar, Zahra Javid, Ali Sahraian, Sina Jelodar

Connect to this object online.

The role of psychosocial factors in explaining sex differences in major depression and generalized anxiety during the COVID-19 pandemic by Frédérique Vallières, Jamie Murphy, Orla McBride, Mark Shevlin, Brynne Gilmore, Áine Travers, Ann Nolan, Sarah Butter, Thanos Karatzias, Richard Bentall, Philip Hyland

Connect to this object online.

Sex differences in erythrocyte fatty acid composition of first-diagnosed, drug-naïve patients with major depressive disorders by Lu Wang, Lu Wang, Lu Wang, Ting Liu, Ting Liu, Jimin Guo, Tingyu Zhao, Tingyu Zhao, Hui Tang, Fang Dong, Fang Dong, Chuanyue Wang, Chuanyue Wang, Jindong Chen, Mimi Tang, Mimi Tang

Connect to this object online.

Clinical perspectives on the influence of drug formulation on patient tolerability and use of commonly prescribed antidepressants in major depressive disorder by Matthew A Fuller, Martha Sajatovic, Lata Handiwala

Connect to this object online.

Major Depressive Disorder in a Patient with Systemic Lupus Erythematous, Pulmonary Hypertension, and Hypercoagulation: A Case Report by Muhammad Yamin, Edward Faisal, Rudi Putranto, Hamzah Shatri

Connect to this object online.

Efficacy and tolerability of vilazodone for major depressive disorder: evidence from phase III/IV randomized controlled trials by Shi LG, Wang JY, Xu SB, Lu YR

Connect to this object online.

Alterations in the Levels of Growth Factors in Adolescents with Major Depressive Disorder: A Longitudinal Study during the Treatment with Fluoxetine by Enrique Becerril-Villanueva, Gilberto Pérez-Sánchez, Samantha Alvarez-Herrera, Manuel Iván Girón-Pérez, Rodrigo Arreola, Carlos Cruz-Fuentes, Lino Palacios, Francisco R. de la Peña, Lenin Pavón

Connect to this object online.

Comparison of brexpiprazole, aripiprazole, and placebo for Japanese major depressive disorder: A systematic review and network meta‐analysis by Taro Kishi, Kenji Sakuma, Takeo Saito, Atsuo Nakagawa, Masaki Kato, Nakao Iwata

Connect to this object online.

Data Elements for Screening Major Depression in Ages 10 To 25 Using a Clinical Decision Support System by Leila Shahmoradi, Niloofar Kheradbin, Ahmad Reza Farzanehnejad, Niloofar Mohammadzadeh, Atefeh Ghanbari Jolfaei

Connect to this object online.

Major depressive episode in mothers during the COVID-19 pandemic: a population-based study in the Southern Brazil by Fernanda Teixeira Coelho, Carolina Coelho Scholl, Jéssica Puchalski Trettim, Jaqueline Buzetto Silveira, Daniele Behling de Mello, Martha Rodrigues dos Santos, Lidiane Aguiar Ferreira, Rafaelle Stark Stigger, Mariana Bonati de Matos, Ricardo Tavares Pinheiro, Luciana de Avila Quevedo

Connect to this object online.

Knowledge and Attitude of Families with Major Depression Patient referring to Shafa Hospital in Rasht regarding Treatment Follow up by ali Tabaei, hayedeh mahmuodi, mojgan Baghaie, ehsan kazemnezhad

Connect to this object online.

Cross-Domain Identification of Multisite Major Depressive Disorder Using End-to-End Brain Dynamic Attention Network by Xue Yuan, Maozhou Chen, Peng Ding, Anan Gan, Anmin Gong, Zhaosong Chu, Wenya Nan, Yunfa Fu, Yuqi Cheng

Connect to this object online.

<i>CYP2C19</i> Genetic Variants and Major Depressive Disorder: A Systematic Review by Larissa Sousa Silva Bonasser, Calliandra Maria de Souza Silva, Caroline Ferreira Fratelli, Bruna Rodrigues Gontijo, Juliana Moura Alves Seixas, Livia Cristina Lira de Sá Barreto, Izabel Cristina Rodrigues da Silva

Connect to this object online.

Factors related to the length of stay for major depressive disorder patients in China: A real-world retrospective study by Peng Cheng, Lirong Wang, Lizhi Xu, Ying Zhou, Guangju Zhao, Li Zhang, Weihui Li

Connect to this object online.

Exploring life engagement from the perspective of patients with major depressive disorder: a study using patient interviews by François Therrien, Stine R. Meehan, Catherine Weiss, Jennifer Dine, T. Michelle Brown, Erin M. MacKenzie

Connect to this object online.

Treatment of alcohol dependence in patients with co-morbid major depressive disorder - predictors for the outcomes with memantine and escitalopram medication by Lönnqvist Jouko, Sinclair David, Lahti Jari, Muhonen Leea H, Alho Hannu

Connect to this object online.

Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial by Hashemi SN, Ghafarian Shirazi HR, Mohammadi A, Zadeh-Bagheri GH, Noorian KH, Malekzadeh M

Connect to this object online.

Engagement With a Remote Symptom-Tracking Platform Among Participants With Major Depressive Disorder: Randomized Controlled Trial by Katie M White, Ewan Carr, Daniel Leightley, Faith Matcham, Pauline Conde, Yatharth Ranjan, Sara Simblett, Erin Dawe-Lane, Laura Williams, Claire Henderson, Matthew Hotopf

Connect to this object online.